Abstract
Many workers have attempted to assign specific functions to catecholamines in the central nervous system, since Vogt (1954) demonstrated their presence in different areas of brain. Vedernikov and Afrikanov (1969) have reported that pretreatment with reserpine reduced the analgesic activity of morphine. Subsequently Vedernikov (1970) observed that prior administration of pyrogallol, cocaine and iproniazid also potentiated the analgesic activity of morphine. On the basis of these observations noradrenaline (NA) has been suggested as playing a significant role in the analgesic activity of morphine. The possibility of NA being a neurotransmitter at the spinothalamic pathways which transmit nociceptive impulses has also been postulated. Even though in most of these experiments there is also a change in dopamine (DA) levels in the same direction, these workers have not attached much significance to changes in DA level. Recently however, DA has also been increasingly considered to have important functions at subcortical structures such as striatum and substantia nigra. In these areas, its presence in the presynaptic nerve endings has been demonstrated by histochemical methods (Dahlström and Fuxe, 1964). The involvement of dopaminergic mechanisms in morphine analgesia has recently been suggested by some workers (Calcutt, Doggett and Spencer, 1971; Carroll and Sharp 1972). The present study was undertaken to further investigate the possible role of DA in the antinociceptive (analgesic) activity of morphine.
This is a preview of subscription content, log in via an institution.
Preview
Unable to display preview. Download preview PDF.
References
Bhargava, H. N. and Way, E. L. (1974). ‘Effect of 1-phenyl-3-(2-thiazolyl)-2-thiourea, a dopamine -ß-hydroxylase inhibitor on morphine analgesia, tolerance and physical dependence’, J. Pharmac. exp. Ther., 190, 165–175
Calcutt, C. R., Doggett, N. S. and Spencer, P. S. J. (1971). ‘Modification of the anti-nociceptive activity of morphine by centrally administered ouabain and dopamine’, Psychopharmacologia (Berl.), 21, 111–117
Carroll, B. J. and Sharp, P. T. (1972). ‘Monoamine mediation of morphine-induced activation of mice’, Br. J. Pharmac., 76, 124–139
Dahlström, A. and Fuxe, K. (1964). ‘Evidence for the existence of monoamine containing neurones in the central nervous system. I Demonstration of monoamines in the cell bodies of brain stem neurones’, Acta physiol. scand. 232, 1–55
Dhawan, B. N. and Gupta, G. P. (1959). ‘LSD-25 antagonism of morphine analgesia’, Archs int. Pharmacodyn. Ther., 128, 132–139
Doggett, N. S., Spencer, P. S. J. and Turner T. A. R. (1970). ‘The pharmacological effects of ouabain administered intracerebrally to conscious mice’, Br. J. Pharmac., 40, 138–139 P
Feltz, P., Krauthamer, G. and Albe-Fessard, D. (1967). ‘Neurons of the medial diencephalen. I. somato-sensory responses and caudate inhibition’, J. Neurophysiol., 30, 55–80
Finney, D. J. (1952). Probit Analysis, 2nd Edn, Cambridge University Press, Cambridge
Florvall, L. and Corrodi, H. (1970). Dopamine-β-hydroxylase inhibitors’ Acta Pharmac. Suecia, 7, 7–22
Krauthamer, G. M. and Albe-Fessard, D. (1964). Electrophysiologic studies of the basal ganglia and striopallidal inhibition of non-specific afferent activity’, Neurophysiologia, 2, 73–83
Lotti, V. J. and Porter, C. C. (1970). ‘Potentiation and inhibition of some central actins oft. ( — )-dopa by decarboxylase inhibitors’, J. Pharmac. exp. Ther., 172, 406–415
Lupina, I. Z., Kleinrokz, Z. and Smolarz, J. (1971). ‘The effect of sodium diethyldithiocarbamate on the action of analgesics in albino mice’, Diss. Pharm. Pharmac., 23, 33–39
Saarnivaara, L. (1969). ‘Analgesic activity of some sympathetic drugs and their effect on morphine analgesia in rabbits’, Ann. Med., exp. Fenn., 47, 180–190
Smith, C. B., Villareal, J. E. Bednarczyk, J. H. and Sheldon, M. I. (1970). ‘Tolerance of morphine induced increase in (14C) catecholamine synthesis in mouse brain’, Science, 170, 1106–1108
Vedernikov, Yu. P. (1970). ‘The role of brain catecholamines in morphine analgesic action in morphine tolerant rats’, J. Pharm. Pharmac., 22, 238–239
Vedernikov, Yu. P. and Afrikanov, I. I. (1969). ‘On the role of central adrenergic mechanism in morphine analgesic action’, J. Pharm. Pharmac., 21, 845–847
Vogt, M. (1954). ‘The concentration of sympathin in different parts of the central nervous system under normal conditions and after the administration of drugs’, J. Physiol., Land., 123, 451–481
Way, E. L., Loh, H. H. and Shen, F. (1968). Morphine tolerance, physical dependence and synthesis of brain 5-hydroxytryptamine’, Science, 162, 1290–1292
Weis, J. (1969). ‘Morphine antagonistic effect of chlordiazepoxide (Librium)’, Experientia, 25, 381
Woolfe G. And Macdonald. A. D. (1944). ‘The evaluation of analgesic action of pethidine hydrochloride (Demerol)’, J. Pharmac. exp. Ther., 80, 300–307
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Copyright information
© 1976 The Contributors
About this chapter
Cite this chapter
Singh, G.B., Sharmat, J.N., Dhawan, B.N. (1976). Possible involvement of a dopaminergic link in the analgesic action of morphine. In: Bradley, P.B., Dhawan, B.N. (eds) Drugs and Central Synaptic Transmission. Palgrave, London. https://doi.org/10.1007/978-1-349-01247-3_32
Download citation
DOI: https://doi.org/10.1007/978-1-349-01247-3_32
Publisher Name: Palgrave, London
Print ISBN: 978-1-349-01249-7
Online ISBN: 978-1-349-01247-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)